As of 2024-12-15, the Relative Valuation of Theravance Biopharma Inc (TBPH) is (6.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.88 USD, the upside of Theravance Biopharma Inc based on Relative Valuation is -167.6%.
The range of the Relative Valuation is (6.43) - (7.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.9x - 9.9x | 6.5x |
| Forward P/E multiples | 6.4x - 7.6x | 6.8x |
| Fair Price | (6.43) - (7.68) | (6.68) |
| Upside | -165.1% - -177.7% | -167.6% |
| Date | P/E |
| 2024-12-13 | -9.83 |
| 2024-12-12 | -9.82 |
| 2024-12-11 | -9.99 |
| 2024-12-10 | -10.03 |
| 2024-12-09 | -9.94 |
| 2024-12-06 | -9.83 |
| 2024-12-05 | -9.79 |
| 2024-12-04 | -9.55 |
| 2024-12-03 | -9.79 |
| 2024-12-02 | -9.40 |
| 2024-11-29 | -9.21 |
| 2024-11-27 | -9.38 |
| 2024-11-26 | -9.20 |
| 2024-11-25 | -9.43 |
| 2024-11-22 | -9.43 |
| 2024-11-21 | -9.57 |
| 2024-11-20 | -9.92 |
| 2024-11-19 | -9.87 |
| 2024-11-18 | -9.45 |
| 2024-11-15 | -9.48 |
| 2024-11-14 | -9.53 |
| 2024-11-13 | -9.63 |
| 2024-11-12 | -8.87 |
| 2024-11-11 | -9.04 |
| 2024-11-08 | -8.90 |
| 2024-11-07 | -8.71 |
| 2024-11-06 | -8.67 |
| 2024-11-05 | -8.23 |
| 2024-11-04 | -8.17 |
| 2024-11-01 | -8.24 |
| 2024-10-31 | -8.20 |
| 2024-10-30 | -8.43 |
| 2024-10-29 | -8.61 |
| 2024-10-28 | -8.73 |
| 2024-10-25 | -8.51 |
| 2024-10-24 | -8.60 |
| 2024-10-23 | -8.59 |
| 2024-10-22 | -8.76 |
| 2024-10-21 | -8.62 |
| 2024-10-18 | -8.76 |
| 2024-10-17 | -8.58 |
| 2024-10-16 | -8.66 |
| 2024-10-15 | -8.56 |
| 2024-10-14 | -8.19 |
| 2024-10-11 | -8.27 |
| 2024-10-10 | -8.02 |
| 2024-10-09 | -8.02 |
| 2024-10-08 | -7.89 |
| 2024-10-07 | -8.01 |
| 2024-10-04 | -8.06 |